Page last updated: 2024-09-04

sandoz-21-009 and phenylephrine

sandoz-21-009 has been researched along with phenylephrine in 1 studies

Compound Research Comparison

Studies (sandoz-21-009)	Trials (sandoz-21-009)	Recent Studies (post-2010) (sandoz-21-009)	Studies (phenylephrine)	Trials (phenylephrine)	Recent Studies (post-2010) (phenylephrine)
19	0	0	13,797	857	2,083

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hosohata, Y; Karakisawa, Y; Maruyama, K; Nagatomo, T; Sasaki, K; Suzuki, M; Tsuchihashi, H	1

Other Studies

1 other study(ies) available for sandoz-21-009 and phenylephrine

Article	Year
Alpha-1 and beta-adrenergic receptor blocking potencies of bopindolol and its two metabolites (18-502 and 20-785) as assessed by radioligand binding assay methods. General pharmacology, 1995, Volume: 26, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Cattle; Dogs; Heart; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Myocardium; Phenylephrine; Pindolol; Radioligand Assay; Rats; Spleen; Trachea	1995

Article

Year

Alpha-1 and beta-adrenergic receptor blocking potencies of bopindolol and its two metabolites (18-502 and 20-785) as assessed by radioligand binding assay methods.

General pharmacology, 1995, Volume: 26, Issue:4

Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Cattle; Dogs; Heart; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Myocardium; Phenylephrine; Pindolol; Radioligand Assay; Rats; Spleen; Trachea

1995